insights_auto
Outlook: 80.0% bullish·0.0% bearish
Go to analysischevron_right
ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$56.91
arrow_upward
+1.81%(+1.01) 1D
Oct 19, 11:29:22 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$56.96
High
$57.25
Low
$56.05
Mkt. cap
8.04B
Avg. vol.
2.29M
Volume
363.31K
52-wk high
$95.49
52-wk low
$36.73
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
Open
$56.96
High
$57.25
Low
$56.05
Mkt. cap
8.04B
Avg. vol.
2.29M
Volume
363.31K
52-wk high
$95.49
52-wk low
$36.73
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
Mahoning Matters
·
2 minutes ago
S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
HDFC Sky
·
38 minutes ago
Nasdaq Jumps 259 Points to 26,399 as Intel Surges 5.5% and AI Stocks Rebound After Brutal Selloff
TipRanks
·
31 minutes ago
Dow Jones Steady as AI Stocks Rebound from Selloff
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.08% Lower
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com